natural glp-1 agonist for weight loss Nutritional priorities to support therapy obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society The expanding therapeutic landscape of

This shorter observation period reflects its recent market entry and may underestimate cumulative risks

It has been around since 1959, making it one of the longest-standing FDA-approved weight loss medications in the United States

Liu Y, Ruan B, Jiang H, Le S, Liu Y, Ao X, et al

SUSTAIN-6 reported a reduction in non-fatal stroke, while the Harmony Outcomes trials observed a reduction in non-fatal MI, and the LEADER trial observed fewer deaths from cardiovascular causes in the liraglutide group than in the placebo group

[17] In January 2023, the US FDA prescription label for Rybelsus was updated to reflect that it can be used as a first-line treatment for adults with type 2 diabetes

Systemic effects of GLP-1 RAs, mediated via GLP-1 receptors in other organs and systems, include enhanced endothelial function and myocardial metabolism, natriuresis and anti-inflammatory and blood pressure-lowering effects